{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:23:48Z","timestamp":1781886228152,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671940"],"award-info":[{"award-number":["81671940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871586"],"award-info":[{"award-number":["81871586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017616","name":"Beijing Talents Foundation","doi-asserted-by":"crossref","award":["2018000021223ZK27"],"award-info":[{"award-number":["2018000021223ZK27"]}],"id":[{"id":"10.13039\/501100017616","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and technology commission","doi-asserted-by":"crossref","award":["Z201100005420012"],"award-info":[{"award-number":["Z201100005420012"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Traditional Chinese Medicine Development Funding of Science and Technology","award":["YJ2020-01"],"award-info":[{"award-number":["YJ2020-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thrombosis and coagulopathy are highly prevalent in critically ill patients with COVID-19 and increase the risk of death. Immunothrombosis has recently been demonstrated to contribute to the thrombotic events in COVID-19 patients with coagulopathy. As the primary components of immunothrombosis, neutrophil extracellular traps (NETs) could be induced by complement cascade components and other proinflammatory mediators. We aimed to explore the clinical roles of NETs and the regulation of complement on the NET formation in COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited 135 COVID-19 patients and measured plasma levels of C5, C3, cell-free DNA and myeloperoxidase (MPO)-DNA. Besides, the formation of NETs was detected by immunofluorescent staining and the cytotoxicity to vascular endothelial HUVEC cells was evaluated by CCK-8 assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that the plasma levels of complements C3 and MPO-DNA were positively related to coagulation indicator fibrin(-ogen) degradation products (C3:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.300,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005; MPO-DNA:\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.316,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002) in COVID-19 patients. Besides, C3 was positively related to direct bilirubin (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.303,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004) and total bilirubin (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.304,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), MPO-DNA was positively related to lactate dehydrogenase (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.306,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and creatine kinase (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.308,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). By using anti-C3a and anti-C5a antibodies, we revealed that the complement component anaphylatoxins in the plasma of COVID-19 patients strongly induced NET formation. The pathological effect of the anaphylatoxin-NET axis on the damage of vascular endothelial cells could be relieved by recombinant carboxypeptidase B (CPB), a stable homolog of enzyme CPB2 which can degrade anaphylatoxins to inactive products.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over-activation in anaphylatoxin-NET axis plays a pathological role in COVID-19. Early intervention in anaphylatoxins might help prevent thrombosis and disease progression in COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-021-03482-z","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T17:44:17Z","timestamp":1612806257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Carboxypeptidase B blocks ex vivo activation of the anaphylatoxin-neutrophil extracellular trap axis in neutrophils from COVID-19 patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-6061","authenticated-orcid":false,"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuluan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"3482_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020;191:148\u201350.","journal-title":"Thromb Res"},{"issue":"4","key":"3482_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"3482_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. Jama. 2020;324(8):782\u201393.","journal-title":"Jama"},{"issue":"4","key":"3482_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schroder AS, et al. Autopsy findings and venous thromboembolism in patients with COVID-19. Ann Intern Med. 2020;173(4):268\u201377.","journal-title":"Ann Intern Med"},{"key":"3482_CR5","doi-asserted-by":"publisher","first-page":"107227","DOI":"10.1016\/j.carpath.2020.107227","volume":"48","author":"Z Grimes","year":"2020","unstructured":"Grimes Z, Bryce C, Sordillo EM, Gordon RE, Reidy J, Paniz Mondolfi AE, Fowkes M. Fatal pulmonary thromboembolism in SARS-CoV-2-infection. Cardiovasc Pathol. 2020;48:107227.","journal-title":"Cardiovasc Pathol"},{"key":"3482_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2020.04.018","volume":"307","author":"WC Schrottmaier","year":"2020","unstructured":"Schrottmaier WC, Mussbacher M, Salzmann M, Assinger A. Platelet-leukocyte interplay during vascular disease. Atherosclerosis. 2020;307:109\u201320.","journal-title":"Atherosclerosis"},{"issue":"10","key":"3482_CR7","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2020007008","volume":"136","author":"EA Middleton","year":"2020","unstructured":"Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, et al. Neutrophil extracellular traps (NETs) contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136(10):1169\u201379.","journal-title":"Blood"},{"issue":"6","key":"3482_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/blood-2018-11-886267","volume":"133","author":"R Palankar","year":"2019","unstructured":"Palankar R, Greinacher A. Challenging the concept of immunothrombosis. Blood. 2019;133(6):508\u20139.","journal-title":"Blood"},{"issue":"3","key":"3482_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.thromres.2011.10.010","volume":"129","author":"C Cerletti","year":"2012","unstructured":"Cerletti C, Tamburrelli C, Izzi B, Gianfagna F, de Gaetano G. Platelet-leukocyte interactions in thrombosis. Thromb Res. 2012;129(3):263\u20136.","journal-title":"Thromb Res"},{"issue":"7","key":"3482_CR10","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-5247(20)30144-0","volume":"1","author":"B Schurink","year":"2020","unstructured":"Schurink B, Roos E, Radonic T, Barbe E, Bouman CSC, de Boer HH, de Bree GJ, Bulle EB, Aronica EM, Florquin S, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1(7):e290\u20139.","journal-title":"Lancet Microbe"},{"issue":"2","key":"3482_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","volume":"188","author":"R Lubbers","year":"2017","unstructured":"Lubbers R, van Essen MF, van Kooten C, Trouw LA. Production of complement components by cells of the immune system. Clin Exp Immunol. 2017;188(2):183\u201394.","journal-title":"Clin Exp Immunol"},{"issue":"14","key":"3482_CR12","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","volume":"46","author":"A Klos","year":"2009","unstructured":"Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Kohl J. The role of the anaphylatoxins in health and disease. Mol Immunol. 2009;46(14):2753\u201366.","journal-title":"Mol Immunol"},{"issue":"1","key":"3482_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/imr.12473","volume":"274","author":"A Verschoor","year":"2016","unstructured":"Verschoor A, Karsten CM, Broadley SP, Laumonnier Y, Kohl J. Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments. Immunol Rev. 2016;274(1):112\u201326.","journal-title":"Immunol Rev"},{"key":"3482_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.smim.2018.03.002","volume":"37","author":"CD Sadik","year":"2018","unstructured":"Sadik CD, Miyabe Y, Sezin T, Luster AD. The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin. Semin Immunol. 2018;37:21\u20139.","journal-title":"Semin Immunol"},{"issue":"23","key":"3482_CR15","doi-asserted-by":"publisher","first-page":"9439","DOI":"10.1073\/pnas.1218815110","volume":"110","author":"MC Wu","year":"2013","unstructured":"Wu MC, Brennan FH, Lynch JP, Mantovani S, Phipps S, Wetsel RA, Ruitenberg MJ, Taylor SM, Woodruff TM. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization. Proc Natl Acad Sci USA. 2013;110(23):9439\u201344.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3482_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1681\/ASN.2008050497","volume":"20","author":"A Schreiber","year":"2009","unstructured":"Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol JASN. 2009;20(2):289\u201398.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"5","key":"3482_CR17","doi-asserted-by":"publisher","first-page":"e64443","DOI":"10.1371\/journal.pone.0064443","volume":"8","author":"CC Garcia","year":"2013","unstructured":"Garcia CC, Weston-Davies W, Russo RC, Tavares LP, Rachid MA, Alves-Filho JC, Machado AV, Ryffel B, Nunn MA, Teixeira MM. Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury. PLoS ONE. 2013;8(5):e64443.","journal-title":"PLoS ONE"},{"issue":"1","key":"3482_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jre.12284","volume":"51","author":"LJ Palmer","year":"2016","unstructured":"Palmer LJ, Damgaard C, Holmstrup P, Nielsen CH. Influence of complement on neutrophil extracellular trap release induced by bacteria. J Periodontal Res. 2016;51(1):70\u20136.","journal-title":"J Periodontal Res"},{"issue":"11","key":"3482_CR19","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.4049\/jimmunol.180.11.7368","volume":"180","author":"K Kambas","year":"2008","unstructured":"Kambas K, Markiewski MM, Pneumatikos IA, Rafail SS, Theodorou V, Konstantonis D, Kourtzelis I, Doumas MN, Magotti P, Deangelis RA, et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol. 2008;180(11):7368\u201375.","journal-title":"J Immunol"},{"issue":"11","key":"3482_CR20","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1172\/JCI141374","volume":"130","author":"P Skendros","year":"2020","unstructured":"Skendros P, Mitsios A, Chrysanthopoulou A, Mastellos DC, Metallidis S, Rafailidis P, Ntinopoulou M, Sertaridou E, Tsironidou V, Tsigalou C, et al. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis. J Clin Invest. 2020;130(11):6151\u20137.","journal-title":"J Clin Invest"},{"issue":"Pt 6","key":"3482_CR21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1107\/S139900471400844X","volume":"70","author":"JA Schatz-Jakobsen","year":"2014","unstructured":"Schatz-Jakobsen JA, Yatime L, Larsen C, Petersen SV, Klos A, Andersen GR. Structural and functional characterization of human and murine C5a anaphylatoxins. Acta Crystallogr D Biol Crystallogr. 2014;70(Pt 6):1704\u201317.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"11","key":"3482_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.molimm.2003.10.002","volume":"40","author":"KW Matthews","year":"2004","unstructured":"Matthews KW, Mueller-Ortiz SL, Wetsel RA. Carboxypeptidase N: a pleiotropic regulator of inflammation. Mol Immunol. 2004;40(11):785\u201393.","journal-title":"Mol Immunol"},{"issue":"5","key":"3482_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/jth.13964","volume":"16","author":"J Morser","year":"2018","unstructured":"Morser J, Shao Z, Nishimura T, Zhou Q, Zhao L, Higgins J, Leung LLK. Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice. J Thromb Haemost. 2018;16(5):991\u20131002.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3482_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jth.13999","volume":"16","author":"JH Foley","year":"2018","unstructured":"Foley JH, Conway EM. Basic weapons to degrade C3a and C5a. J Thromb Haemost. 2018;16(5):987\u201390.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"3482_CR25","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/jth.13168","volume":"13","author":"JH Foley","year":"2015","unstructured":"Foley JH, Kim PY, Hendriks D, Morser J, Gils A, Mutch NJ. Subcommittee on F: Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(12):2277\u20138.","journal-title":"J Thromb Haemost"},{"key":"3482_CR26","doi-asserted-by":"crossref","unstructured":"Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl) 2020, 133(9):1087\u20131095.","DOI":"10.1097\/CM9.0000000000000819"},{"issue":"9","key":"3482_CR27","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/cid\/ciz553","volume":"70","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Song R, Shen Y, Zhao Y, Zhao Z, Fan T, Yang X, Wang L, Zhang W, Chen C, et al. High levels of circulating cell-free DNA are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2020;70(9):1941\u20139.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3482_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/infdis\/jix475","volume":"217","author":"L Zhu","year":"2018","unstructured":"Zhu L, Liu L, Zhang Y, Pu L, Liu J, Li X, Chen Z, Hao Y, Wang B, Han J, et al. High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza a infection. J Infect Dis. 2018;217(3):428\u201337.","journal-title":"J Infect Dis"},{"issue":"9","key":"3482_CR29","first-page":"3517","volume":"121","author":"JJ Song","year":"2011","unstructured":"Song JJ, Hwang I, Cho KH, Garcia MA, Kim AJ, Wang TH, Lindstrom TM, Lee AT, Nishimura T, Zhao L, et al. Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis. J Clin Invest. 2011;121(9):3517\u201327.","journal-title":"J Clin Invest"},{"issue":"1","key":"3482_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jvs.2020.08.029","volume":"73","author":"A Manenti","year":"2020","unstructured":"Manenti A, Farinetti A, Manco G, Mattioli A. Vasculitis and aortitis: Covid-19 challenging complications. J Vasc Surg. 2020;73(1):347\u20138.","journal-title":"J Vasc Surg"},{"key":"3482_CR31","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","volume":"58","author":"M Leppkes","year":"2020","unstructured":"Leppkes M, Knopf J, Naschberger E, Lindemann A, Singh J, Herrmann I, Sturzl M, Staats L, Mahajan A, Schauer C, et al. Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020;58:102925.","journal-title":"EBioMedicine"},{"issue":"6","key":"3482_CR32","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"BJ Barnes","year":"2020","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford JM, Dassler-Plenker J, Guerci P, Huynh C, Knight JS, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652.","journal-title":"J Exp Med"},{"issue":"20","key":"3482_CR33","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2018-10-862243","volume":"133","author":"DF Noubouossie","year":"2019","unstructured":"Noubouossie DF, Reeves BN, Strahl BD, Key NS. Neutrophils: back in the thrombosis spotlight. Blood. 2019;133(20):2186\u201397.","journal-title":"Blood"},{"issue":"10","key":"3482_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nbt1248","volume":"24","author":"H Lee","year":"2006","unstructured":"Lee H, Zahra D, Vogelzang A, Newton R, Thatcher J, Quan A, So T, Zwirner J, Koentgen F, Padkjaer SB, et al. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies. Nat Biotechnol. 2006;24(10):1279\u201384.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3482_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1074-7613(03)00206-1","volume":"19","author":"NC Riedemann","year":"2003","unstructured":"Riedemann NC, Guo RF, Bernacki KD, Reuben JS, Laudes IJ, Neff TA, Gao H, Speyer C, Sarma VJ, Zetoune FS, et al. Regulation by C5a of neutrophil activation during sepsis. Immunity. 2003;19(2):193\u2013202.","journal-title":"Immunity"},{"issue":"6","key":"3482_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/annrheumdis-2015-207338","volume":"75","author":"A Cumpelik","year":"2016","unstructured":"Cumpelik A, Ankli B, Zecher D, Schifferli JA. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome. Ann Rheum Dis. 2016;75(6):1236\u201345.","journal-title":"Ann Rheum Dis"},{"issue":"35","key":"3482_CR37","doi-asserted-by":"publisher","first-page":"eaav5951","DOI":"10.1126\/sciimmunol.aav5951","volume":"4","author":"Y Miyabe","year":"2019","unstructured":"Miyabe Y, Miyabe C, Mani V, Mempel TR, Luster AD. Atypical complement receptor transports C5aR2 to initiate neutrophil adhesion and inflammation. Sci Immunol. 2019;4(35):eaav5951.","journal-title":"Sci Immunol"},{"issue":"7","key":"3482_CR38","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1126\/sciimmunol.aaj2195","volume":"2","author":"Y Miyabe","year":"2017","unstructured":"Miyabe Y, Miyabe C, Murooka TT, Kim EY, Newton GA, Kim ND, Haribabu B, Luscinskas FW, Mempel TR, Luster AD. Complement C5a receptor is the key initiator of neutrophil adhesion igniting immune complex-induced arthritis. Sci Immunol. 2017;2(7):2195.","journal-title":"Sci Immunol"},{"key":"3482_CR39","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","volume":"220","author":"DC Mastellos","year":"2020","unstructured":"Mastellos DC, Pires da Silva BGP, Fonseca BAL, Fonseca NP, Auxiliadora-Martins M, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, et al. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Clin Immunol. 2020;220:108598.","journal-title":"Clin Immunol"},{"issue":"9","key":"3482_CR40","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/jth.14981","volume":"18","author":"AJ Chauhan","year":"2020","unstructured":"Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. 2020;18(9):2110\u20137.","journal-title":"J Thromb Haemost"},{"issue":"13","key":"3482_CR41","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.7150\/ijms.47935","volume":"17","author":"X Xu","year":"2020","unstructured":"Xu X, Yu MQ, Shen Q, Wang LZ, Yan RD, Zhang MY, Liu JY, Qu YQ. Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan China. Int J Med Sci. 2020;17(13):2052\u201362.","journal-title":"Int J Med Sci"},{"issue":"17","key":"3482_CR42","doi-asserted-by":"publisher","first-page":"e140289","DOI":"10.1172\/jci.insight.140289","volume":"5","author":"JG Wilson","year":"2020","unstructured":"Wilson JG, Simpson LJ, Ferreira AM, Rustagi A, Roque J, Asuni A, Ranganath T, Grant PM, Subramanian A, Rosenberg-Hasson Y, et al. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. 2020;5(17):e140289.","journal-title":"JCI Insight"},{"issue":"10229","key":"3482_CR43","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. Hlh Across Speciality Collaboration UK: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033\u20134.","journal-title":"Lancet"},{"issue":"3","key":"3482_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1348-0421.2011.00309.x","volume":"55","author":"R Ohta","year":"2011","unstructured":"Ohta R, Torii Y, Imai M, Kimura H, Okada N, Ito Y. Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza. Microbiol Immunol. 2011;55(3):191\u20138.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"3482_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nm836","volume":"9","author":"M Basta","year":"2003","unstructured":"Basta M, Van Goor F, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L, Szebeni J, Alving CR, Carroll MC, Berkower I, et al. F(ab)\u20192-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med. 2003;9(4):431\u20138.","journal-title":"Nat Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-021-03482-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03482-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T17:52:29Z","timestamp":1612806749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03482-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3482"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03482-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-75543\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"9 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Committee of Ethics at Beijing Ditan Hospital, Capital Medical University, Beijing, China, and each patient gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"51"}}